SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-20 |
| Reported value | $723,718,198 |
| Positions | 52 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| PTC THERAPEUTICS INC | PTCT | COM | $74,950,268 | 918,846 |
| ACADIA PHARMACEUTICALS INC | ACAD | COM | $72,461,629 | 2,864,096 |
| INSMED INC | INSM | COM PAR $.01 | $44,138,548 | 413,980 |
| MIRUM PHARMACEUTICALS INC | MIRM | COM | $40,834,953 | 348,808 |
| ANAPTYSBIO INC | ANAB | COM | $40,735,508 | 603,489 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | COM | $39,068,500 | 682,777 |
| DYNE THERAPEUTICS INC | DYN | COM | $36,591,441 | 1,647,521 |
| UNITED THERAPEUTICS CORP | UTHR | COM | $33,911,514 | 62,587 |
| DISC MEDICINE INC | IRON | COM | $30,473,488 | 416,646 |
| BIOGEN INC | BIIB | COM | $30,308,681 | 140,279 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.